Colon rectal neoplasia differentially expressed (CRNDE) promotes DSS-induced apoptosis of colon epithelial cells by inhibiting miR-495 and increasing suppressor of cytokine signaling 1 (SOCS1), suggesting that CRNDE is a target for IBD treatment [51]. The gene discussed is SOCS1; the disease is inflammatory bowel disease.